Anroop B Nair
Cited by
Cited by
A simple practice guide for dose conversion between animals and human
AB Nair, S Jacob
Journal of basic and clinical pharmacy 7 (2), 27-31, 2016
In vitro techniques to evaluate buccal films
AB Nair, R Kumria, S Harsha, M Attimarad, BE Al-Dhubiab, IA Alhaider
Journal of Controlled Release 166 (1), 10-21, 2013
Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis
AB Nair, HD Kim, B Chakraborty, J Singh, M Zaman, A Gupta, PM Friden, ...
Journal of pharmaceutical sciences 98 (11), 4130-4140, 2009
An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs
S Jacob, AB Nair
Drugs in R&D 16 (4), 303-316, 2016
Understanding type 1 diabetes: etiology and models
S Acharjee, B Ghosh, BE Al-Dhubiab, AB Nair
Canadian journal of diabetes 37 (4), 269-276, 2013
Formulation and evaluation of enteric coated tablets of proton pump inhibitor
AB Nair, R Gupta, R Kumria, S Jacob, M Attimarad
Journal of basic and clinical pharmacy 1 (4), 215-221, 2010
Development of validated RP HPLC method with fluorescence detection for simultaneous quantification of sacubitril and valsartan from rat plasma
M Attimarad, SH Nagaraja, AB Nair, BE Aldhubaib, VN Katharigatta
Journal of Liquid Chromatography & Related Technologies 41 (5), 246-252, 2018
Emulsion forming drug delivery system for lipophilic drugs
J Wadhwa, A Nair, R Kumria
Acta Pol Pharm 69 (2), 179-91, 2012
Enhancement of dissolution rate of valdecoxib by solid dispersions technique with PVP K 30 & PEG 4000: preparation and in vitro evaluation
J Shah, S Vasanti, B Anroop, H Vyas
Journal of Inclusion Phenomena and Macrocyclic Chemistry 63 (1), 69-75, 2009
UPLC: a preeminent technique in pharmaceutical analysis
A Kumar, G Saini, A Nair, R Sharma
Acta Pol Pharm 69 (3), 371-380, 2012
An overview of nutraceuticals: current scenario
S Gupta, D Chauhan, K Mehla, P Sood, A Nair
Journal of basic and clinical pharmacy 1 (2), 55-62, 2010
Dose translation between laboratory animals and human in preclinical and clinical phases of drug development
A Nair, MA Morsy, S Jacob
Drug development research 79 (8), 373-382, 2018
Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin
AB Nair, M Attimarad, BE Al-Dhubiab, J Wadhwa, S Harsha, M Ahmed
Drug delivery 21 (7), 540-547, 2014
Buccal films of prednisolone with enhanced bioavailability
R Kumria, AB Nair, G Goomber, S Gupta
Drug delivery 23 (2), 471-478, 2016
Formulation and evaluation of nano based drug delivery system for the buccal delivery of acyclovir
BE Al-Dhubiab, AB Nair, R Kumria, M Attimarad, S Harsha
Colloids and Surfaces B: Biointerfaces 136, 878-884, 2015
Basic considerations in the dermatokinetics of topical formulations
A Nair, S Jacob, B Al-Dhubiab, M Attimarad, S Harsha
Brazilian journal of pharmaceutical sciences 49 (3), 423-434, 2013
Cyclodextrin complexes: Perspective from drug delivery and formulation
S Jacob, AB Nair
Drug development research 79 (5), 201-217, 2018
Preparation and evaluation of fast-disintegrating effervescent tablets of glibenclamide
S Jacob, A Shirwaikar, A Nair
Drug development and industrial pharmacy 35 (3), 321-328, 2009
Solid lipid nanoparticles: an effective lipid based technology for poorly water soluble drugs
S Kamboj, S Bala, AB Nair
Int J Pharm Sci Rev Res 5 (2), 78-90, 2010
In vitro controlled release of alfuzosin hydrochloride using HPMC-based matrix tablets and its comparison with marketed product
A Nair, R Gupta, S Vasanti
Pharmaceutical development and technology 12 (6), 621-625, 2007
The system can't perform the operation now. Try again later.
Articles 1–20